3D model of heart for Congenital Heart Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Congenital Heart Disease3D model of heart - Other
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare kids who have a 3D printed heart model before VAD surgery to those who don't, to see if the models improve patient outcomes.

Eligible Conditions
  • Congenital Heart Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 5 year

30 day
A change in the clarity of cannula and VAD site demonstration
5 year
Improvement in cardiopulmonary bypass time

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Group B - Control
1 of 2
Group A - 3D models
1 of 2

Active Control

Experimental Treatment

44 Total Participants · 2 Treatment Groups

Primary Treatment: 3D model of heart · No Placebo Group · N/A

Group A - 3D models
Other
Experimental Group · 1 Intervention: 3D model of heart · Intervention Types: Other
Group B - ControlNoIntervention Group · 1 Intervention: Group B - Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 year

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,295 Previous Clinical Trials
1,613,227 Total Patients Enrolled
Kanwal Farooqi, MDPrincipal InvestigatorColumbia University

Eligibility Criteria

Age Any Age · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: